Mirati Therapeutics, Inc.
$58.70▼ 0.17%($-0.10)
TickerSpark Score
57/100
▌ Mixed
40
Valuation
50
Profitability
10
Growth
84
Health
100
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MRTX research report →
52-Week Range85% of range
Low
$27.30
Current
$58.70
High
$64.41
Company Overviewwww.mirati.com
About the company
Mirati Therapeutics, Inc. is a U. S.
- CEO
- Charles M. Baum
- IPO
- 2013
- Employees
- 587
- HQ
- San Diego, CA, US
Price Chart
+22.52% · this period
Valuation
- Market Cap
- $4.12B
- P/E
- -4.45
- P/S
- 331.11
- P/B
- 3.31
- EV/EBITDA
- -5.20
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 95.18%
- Op Margin
- -6107.98%
- Net Margin
- -5957.44%
- ROE
- -61.91%
- ROIC
- -72.27%
Growth & Income
- Revenue
- $12.44M · -82.75%
- Net Income
- $-740,867,000 · -27.34%
- EPS
- $-13.18 · -17.57%
- Op Income
- $-759,589,000
- FCF YoY
- -44.36%
Performance & Tape
- 52W High
- $64.41
- 52W Low
- $27.30
- 50D MA
- $57.69
- 200D MA
- $45.48
- Beta
- 0.77
- Avg Volume
- 1.78M
Get TickerSpark's AI analysis on MRTX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Form 4 · Filings
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 23, 24 | Boxer Capital, LLC | sell | 1,413,475 |
| Jan 23, 24 | Boxer Capital, LLC | sell | 30,518 |
| Jan 23, 24 | Sharp Shalini | sell | 4,162 |
| Jan 23, 24 | Sharp Shalini | sell | 5,252 |
| Jan 23, 24 | Sharp Shalini | sell | 7,520 |
| Jan 23, 24 | Sharp Shalini | sell | 6,808 |
| Jan 23, 24 | Cherrington Julie M | sell | 4,444 |
| Jan 23, 24 | Cherrington Julie M | sell | 6,808 |
| Jan 23, 24 | Cherrington Julie M | sell | 7,520 |
| Jan 23, 24 | Davis Aaron I. | sell | 43,073 |
Coverage · MRTX
Our MRTX coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on MRTX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MRTX report →Internal Compare
Similar companies
Peers in the same neighborhood.
OPT▲1.49%
Opthea Limited
$3.41
SWTX▲0.02%
SpringWorks Therapeutics, Inc.
$46.99
CBAY▲0.03%
CymaBay Therapeutics, Inc.
$32.48
ALPN▲0.02%
Alpine Immune Sciences, Inc.
$64.97
RYZB▲0.02%
RayzeBio, Inc. Common Stock
$62.49
MOR▲2.43%
MorphoSys AG
$18.96
MORF▲0.04%
Morphic Holding, Inc.
$56.99
KDNY▲0.22%
Chinook Therapeutics, Inc.
$40.39